Ad
related to: biontech stock- Learn How To Trade
We can help you invest with speed
& accuracy at every step of a trade
- Trade
Buy, sell, track the market.
Discover our investment products.
- Ranked #1 in Research
Kiplinger's Best Online Brokers
Annual Review from August 31, 2023
- Open an Account
Choose The Account That Works
Best For You, and Start Investing
- Learn How To Trade
Search results
3 Blue-Chip Stocks Set to Triple Soon
InvestorPlace· 10 hours agoInvestors should have a wide range of companies in multiple sectors within their investment portfolio. Companies with a strong reputation and...
Josh Gottheimer's recent transactions in Adobe, Agree Realty, Alphabet and more By Investing.com
Investing.com· 4 days agoJosh Gottheimer's recent transactions in Adobe, Agree Realty, Alphabet and more
Evercore ISI says three years of biotech underperformance may be ending, gives its 5 favorite stocks
CNBC· 7 days agoThe outlook on biotechnology is finally turning positive, according to Evercore ISI, which launched...
S&P 500 Gains and Losses Today: Norwegian Cruise Soars on Guidance, Strategy Update
Investopedia· 22 hours agoIn the days ahead, quarterly results from semiconductor giant Nvidia (NVDA) could provide a gauge of...
Ryvu Therapeutics First Quarter 2024 Financial Results and Corporate Update
FOX 59 Indianapolis· 6 days agoTotal operating revenues in Q1 2024 amounted to $6.4M, compared to $4.3M in Q1 2023. As of May 9,...
Arbutus urged to halt share issuances amid patent disputes By Investing.com
Investing.com· 3 days ago/BioNTech SE. The investment firm, which owns approximately 6.8% of Arbutus, also called for a...
Ryvu Therapeutics to present clinical and preclinical data on RVU120 at the 2024 European Hematology...
FOX 23 News Albany· 7 days agoUpdated data from the Phase I trial of RVU120 in patients with relapsed/refractory acute myeloid...
Vaxxinity leaders detail retreat from 'abusive relationship' after 3 years on public market
FierceBiotech· 6 days agoVaxxinity, which filed to delist from the Nasdaq last month, is choosing radical transparency about...
American exceptionalism on full display in financial markets … or is it?
The Washington Times· 6 days agoThe U.S. economy has confounded forecasters’ dour predictions, but not the optimism of financial...